Encapsulated phenolic-rich blueberry extract alleviates ampicillin-induced gut dysbiosis and reshapes colonic microbial metabolic profiles
Food Bioscience · 2026-11 · 85 · 110182
DOI: 10.1016/j.fbio.2026.110182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Bioscience, 2026-11. Verfasst von Ze Liang und 4 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Melbourne, Faculty of Science, University of Melbourne.
Abstract (Originalsprache)
Antibiotic-induced gut dysbiosis disrupts microbial homeostasis and impairs metabolic functions, making targeted nutritional interventions essential to restore balance and support overall health. This study developed a microencapsulation system for blueberry extracts using maltodextrin (M), gum arabic (GA), and soy protein isolate (SPI) respectively to mitigate ampicillin-induced gut dysbiosis. All formulations maintained an encapsulation efficiency above 85%. SPI-based microcapsules exhibited a superior sustained-release profile, with approximately 60% of phenolic compounds retained to the colonic phase, ensuring enhanced targeted delivery compared to M and GA matrices. During 48 h in vitro colonic fermentation, SPI-encapsulated blueberry extracts alleviated ampicillin-induced dysbiosis by boosting short-chain fatty acid production, particularly acetic, propionic, and butyric acids, significantly outperforming the ampicillin-only treatment group. Microbial profiling indicated that SPI-based microcapsules reshaped the community structure under ampicillin-induced stress by selectively enriching beneficial taxa, including Bifidobacterium and the butyrate-producing genus Anaerostipes . Exploratory shotgun metagenomic analysis provided preliminary insights, suggesting potential trends toward the enrichment of core metabolic pathways and a reduction in the abundance of specific antibiotic resistance genes ( TetQ , TetW , and NimB ). Overall, SPI-based microencapsulation represents a promising strategy to protect blueberry bioactives and support gut microbial homeostasis during antibiotic stress, warranting further replicated studies to validate its impact on the intestinal resistome.
Förderung
- University of Melbourne
- Faculty of Science, University of Melbourne
Zitieren
APA
Liang, Z., Qi, Z., Hu, H., Fang, Z., & Zhang, P. (2026). Encapsulated phenolic-rich blueberry extract alleviates ampicillin-induced gut dysbiosis and reshapes colonic microbial metabolic profiles. Food Bioscience, 85, 110182. https://doi.org/10.1016/j.fbio.2026.110182
Vancouver
Liang Z, Qi Z, Hu H, Fang Z, Zhang P. Encapsulated phenolic-rich blueberry extract alleviates ampicillin-induced gut dysbiosis and reshapes colonic microbial metabolic profiles. Food Bioscience. 2026;85:110182. doi:10.1016/j.fbio.2026.110182
BibTeX
@article{Liang2026,
author = {Liang, Ze and Qi, Ziqi and Hu, Hang-Wei and Fang, Zhongxiang and Zhang, Pangzhen},
title = {Encapsulated phenolic-rich blueberry extract alleviates ampicillin-induced gut dysbiosis and reshapes colonic microbial metabolic profiles},
journal = {Food Bioscience},
year = {2026},
volume = {85},
pages = {110182},
doi = {10.1016/j.fbio.2026.110182}
}
EUVIMED